David Attwood
Financieel Directeur/CFO bij THCinol/CBDinol CanPharma GmbH
Actieve functies van David Attwood
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
THCinol/CBDinol CanPharma GmbH
THCinol/CBDinol CanPharma GmbH Pharmaceuticals: OtherHealth Technology Part of CanPharma GmbH /Jacker/, THCinol/CBDinol CanPharma GmbH is a German company that brings years of experience in the treatment with cannabinoids and necessary expertise to ensure a professional handling of medical cannabis. The company is based in Oranienburg, Germany. The company aims to fully unleash the potential of medical cannabis with a focus on the well-being of the patient. The company offers quality products, specialized information, and a CanPharma patient ID. The company was founded by Holger Sprengel and Henrik Arne Sprengel, with Henrik Arne Sprengel serving as CEO since incorporation. THCinol/CBDinol CanPharma was acquired by CanPharma GmbH /Jacker/ from Health House International Ltd. on November 16, 2022. | Financieel Directeur/CFO | - | - |
Loopbaan van David Attwood
Eerdere bekende functies van David Attwood
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
HEALTH HOUSE INTERNATIONAL | Algemeen Directeur | 10-08-2021 | 19-03-2023 |
Opleiding van David Attwood
The University of Nottingham | Graduate Degree |
Instituto de Estudios Superiores de la Empresa | Masters Business Admin |
Statistieken
Internationaal
Duitsland | 2 |
Verenigd Koninkrijk | 2 |
Spanje | 2 |
Operationeel
Director of Finance/CFO | 1 |
Graduate Degree | 1 |
Masters Business Admin | 1 |
Sectoraal
Health Technology | 3 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
THCinol/CBDinol CanPharma GmbH
THCinol/CBDinol CanPharma GmbH Pharmaceuticals: OtherHealth Technology Part of CanPharma GmbH /Jacker/, THCinol/CBDinol CanPharma GmbH is a German company that brings years of experience in the treatment with cannabinoids and necessary expertise to ensure a professional handling of medical cannabis. The company is based in Oranienburg, Germany. The company aims to fully unleash the potential of medical cannabis with a focus on the well-being of the patient. The company offers quality products, specialized information, and a CanPharma patient ID. The company was founded by Holger Sprengel and Henrik Arne Sprengel, with Henrik Arne Sprengel serving as CEO since incorporation. THCinol/CBDinol CanPharma was acquired by CanPharma GmbH /Jacker/ from Health House International Ltd. on November 16, 2022. | Health Technology |
Health House International Ltd.
Health House International Ltd. Pharmaceuticals: OtherHealth Technology Health House International Ltd. engages in the distribution of medicinal cannabis. The company was founded by Jason Peterson and Harry Karelis in 2014 and is headquartered in Melbourne, Australia. | Health Technology |
- Beurs
- Insiders
- David Attwood
- Ervaring